Abbott, Sucampo win drug OK in Japan; Prosonix in academic pact; New signaling pathway in obesity;

 @FierceBiotech: Nanofactories can synthesize drugs within the body. More | Follow @FierceBiotech

@JohnCFierce: Roche move spotlights NJ's shrinking role in biopharma R&D. Article | Follow @JohnCFierce

 @RyanMFierce: Software could provide a new measuring tool for Parkinson's during clinical trials. Story | Follow @RyanMFierce

> Japanese regulators have approved Amitiza (lubiprostone), a drug from Sucampo and Abbott for the treatment of chronic constipation (excluding constipation caused by organic diseases). Release

> The U.K.'s Prosonix has inked a pact with Imperial College London to accelerate the development of "engineered multi-component Particles" as respiratory medicines. Release

> Biogen Idec and Swedish Orphan Biovitrum launched two global pediatric clinical trials of their long-lasting recombinant Factor VIII and Factor IX Fc fusion proteins in hemophilia A and B. Release

Pharma News

@FiercePharma: Spanish drugmakers can't grow at home, so they're looking for international expansion--Bloomberg. More | Follow @FiercePharma

> Sanofi mulls up to 2,000 job cuts in France, unions say. News

> Sanofi chief among then-GSK execs named in DoJ off-label case. Article

> India's anti-brand stance threatens Big Pharma growth. More

> Italy sharpens up for another €1B in health cuts. Story

Medical Device News

@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @DamianFierce: MDxHealth has signed a deal with Merck KGaA to provide companion diagnostics for a pipeline cancer drug. More | Follow @DamianFierce

> FDA says device-ID plan a 'game-changer.' Story 

> Israeli devicemaker launches smartphone that monitors vitals. Article

> FDA approves OraSure's at-home HIV test. News

Vaccines News

> In $69M IPO bid, GlobeImmune spotlights therapeutic vaccines. Story

> Group tackles dengue vaccine pricing. More

> Soligenix, Infectious Disease Research Institute partner to combat anthrax. Article

> FDA gives Argos green light for kidney cancer immunotherapy. News

Pharma Manufacturing News

 @EricPFierce: China tainted drug capsule scandal leads to new responsibilities for drugmakers. Report | Follow @EricPFierce

> FDA gets device, but not drug tracking .More

> Budget chainsaw may miss Sanofi manufacturing. News

> Glaxo manufacturing must meet special dictates. Story

CRO News

 @NesaNFierce: Argentina is becoming more than the birthplace of Tango, growing in terms of outsourcing. More | Follow @NesaNFierce

> Pernix Therapeutics offers $4.9M for CMO Great Southern Laboratories. Story

> ScinoPharm to build $37M Taiwan plant for cancer injectables. Article

> CMO execs reflect on changing manufacturing front. More

Drug Delivery News

> UPenn turns plant protein into drug-delivery tech. Item

> pSivida eyes FDA approval with trial for Durasert-delivered drug. Story

> InVivo looks to get gel-delivered pain drug on U.S. market. Article

> Northwestern docs deliver siRNA with lotion to stymie cancer. More

> Researchers develop gel to deliver male contraceptive. Story

And Finally… Investigators in Singapore say they have discovered a new signaling pathway that controls both obesity and atherosclerosis. Release

 

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.